期刊文献+

17-β雌二醇对肾间质纤维化防治作用的探讨

17β-estradiol study of effect of estrogen preventing renal interstitial fibrosis
下载PDF
导出
摘要 目的探讨17-β雌二醇对肾间质纤维化防治作用可能的机制。方法雌性SD大鼠30只,随机分为4组:①对照组;②生理雌激素组;③低雌激素组;④17-β雌二醇组。21d后光镜观察单侧梗阻肾组织病理改变;通过免疫组化方法检测转化生长因子(TGF-β1)、α-平滑肌动蛋白(α-SMA);并用RT-PCR方法检测肾组织α-SMAmRNA的表达。结果单侧输尿管梗阻各组出现肾小管间质纤维化改变,其肾组织TGF-β1。和α-SMA表达上调(P〈0.01);与生理雌激素组相比,低雌激素组纤维化病变加重,上述物质表达均明显增多(P〈0.05);而17-β雌二醇组则病变均减轻(P〈0.05)。结论注射17-β雌二醇可能通过下调TGF-β1,和α-SMA的表达,抑制细胞外基质的生成,进而韶到延绣肾间后纤维化的作用. Objective To evaluate the effect of 17β-esfradiol on renal interstitial fibrosis and to explore the possible mechanism. Method Thirty Sprague-Dawley female rats were randomly divided into four groups, control group; normal estrogen group ( rats only underwent UUO) ; low estrogen group (rats were ovariectomized and underwent UUO); high estrogen group (rats underwent UUO and received 17β-estradiol injection). The rats were sacrificed after 21 days, renal tissues were examined by using PAS and Masson stains. Immunohistochemistry was used to determine the protein expressions of TGF-β1 and α-SMA, the mRNA expressions of α-SMA were detected with reverse transcription-polymerase chain reaction. Results Compared with control group, there appeared tubulointerstitial fibrosis developed in UUO groups, the expression of TGF-β1 and α-SMA increased remarkably (P〈0. 01). Compared with UUO group, the lesion was aggravated significantly in UUO + OVX group, with enhanced expression of TGF-β1 andαSMA enhanced (P〈0. 05), and in UUO + E2 group the lesion was attenuated,and the expression of those parameters decreased (P〈0. 05). Conclusions 17β- esfradiol may prevent the development of interstitial fibrosis by inhibiting the over expression of TGF- β1 and αSMA, which may consequently result in the production of extracellular matrix deposition.
出处 《临床肾脏病杂志》 2006年第3期99-101,i0001,共4页 Journal Of Clinical Nephrology
关键词 17-Β雌二醇 肾间质纤维化 转化生长因子-Β1 Α-平滑肌动蛋白 17β-estradiol Interstitial fibrosis TGF-β1 α-SMA
  • 相关文献

参考文献9

  • 1许君望,龚均,冯新利,苌新明,罗金燕,董蕾,贾皑,徐贵平.卵巢切除对四氯化碳诱导大鼠肝纤维化形成的影响[J].基础医学与临床,2003,23(5):551-555. 被引量:4
  • 2薛痕,樊均明,陈亮,苏白海,李孜,胡章学,刘先蓉,许国章.大鼠肾间质纤维化动物模型的实验研究[J].四川动物,2004,23(1):16-20. 被引量:45
  • 3Razzaque MS, Taquchi T. Cellular and molecular events leading to renal tubulointerstitial fibrosis. Med Electron Microsc, 2002,35: 68-80.
  • 4Liu YH. Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol, 2004,15: 1-12.
  • 5Jinde K, Nikolie-Paterson DJ, Huang XR, et al. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis,2001,38: 761-763.
  • 6Kodo S, Kagami S, Urushihara M, et al. Transforming growth factor-betal stimulates collagen matrix remodeling through increased adhesive and contractive potential by human renal fibroblasts. Biochim Biophys Acta, 2004,23: 1693; 2: 91-100.
  • 7Eddy AA. Molecular basis renal fibrosis. Pediatr Nephrol, 2000,15: 290-301.
  • 8Fan JM, Huang XR, Ng YY,et al. Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-betal dependent mechanism in vitro. Am J Kidney Dis,2001,37: 820-831.
  • 9Neugarten J,Acharya A, Silbiger SR Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol, 2000,11: 319-329.

二级参考文献3

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部